| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |